Cargando…

Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge

New vaccine technologies are being investigated for their ability to elicit broadly cross-protective immunity against a range of influenza viruses. We compared the efficacies of two intranasally delivered nonreplicating influenza virus vaccines (H1 and H5 S-FLU) that are based on the suppression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baz, Mariana, Boonnak, Kobporn, Paskel, Myeisha, Santos, Celia, Powell, Timothy, Townsend, Alain, Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620468/ https://www.ncbi.nlm.nih.gov/pubmed/26489862 http://dx.doi.org/10.1128/mBio.01487-15

Ejemplares similares

Respiratory Virus Vaccines
por: Broadbent, Andrew J., et al.
Publicado: (2015)

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
por: Paules, Catharine I, et al.
Publicado: (2017)

Preclinical and clinical developments for combination treatment of influenza
por: Koszalka, Paulina, et al.
Publicado: (2022)

The soft palate is an important site of adaptation for transmissible influenza viruses
por: Lakdawala, Seema S., et al.
Publicado: (2015)

Eagle Effect in Nonreplicating Persister Mycobacteria
por: Wu, Mu-Lu, et al.
Publicado: (2015)

Nonreplicative functions of the origin recognition complex
por: Popova, Varvara V., et al.
Publicado: (2018)

Crystallization of a nonreplicating rotavirus vaccine candidate
por: Hong, Moo Sun, et al.
Publicado: (2021)

Existence and significance of viral nonreplicative RNA recombination
por: Agol, Vadim I.
Publicado: (2023)

Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2016)

Antibiotic Killing of Diversely Generated Populations of Nonreplicating Bacteria
por: McCall, Ingrid C., et al.
Publicado: (2019)

Availability and Accessibility of Live Nonreplicating Smallpox/Mpox Vaccine
por: Kahn, Peter A., et al.
Publicado: (2023)

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
por: Houser, Katherine V., et al.
Publicado: (2018)

Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
por: Kaleli, Ilknur, et al.
Publicado: (2006)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
por: Baz, Mariana, et al.
Publicado: (2022)

Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis
por: Rakesh,, et al.
Publicado: (2014)

Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

1147. A study of high-dose influenza vaccination responses compared to standard-dose in lupus patients: an open- labeled, randomized controlled study
por: Yingyounyong, Sasicha, et al.
Publicado: (2023)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Vaccines for Pandemic Influenza
por: Luke, Catherine J., et al.
Publicado: (2006)

Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery
por: Wang, Y, et al.
Publicado: (2005)

Role of Alanine Dehydrogenase of Mycobacterium tuberculosis during Recovery from Hypoxic Nonreplicating Persistence
por: Giffin, Michelle M., et al.
Publicado: (2016)

Ribosome Rescue Inhibitors Kill Actively Growing and Nonreplicating Persister Mycobacterium tuberculosis Cells
por: Alumasa, John N., et al.
Publicado: (2017)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2015)

Nonreplication of functional connectivity differences in autism spectrum disorder across multiple sites and denoising strategies
por: He, Ye, et al.
Publicado: (2020)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination
por: Yang, Penghui, et al.
Publicado: (2012)

Protein Disulfide Isomerase Inhibitor Suppresses Viral Replication and Production during Antibody-Dependent Enhancement of Dengue Virus Infection in Human Monocytic Cells
por: Rawarak, Nantapon, et al.
Publicado: (2019)

Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019
por: Boonnak, Kobporn, et al.
Publicado: (2021)

Nonreplicative RNA Recombination of an Animal Plus-Strand RNA Virus in the Absence of Efficient Translation of Viral Proteins
por: Kleine Büning, Maximiliane, et al.
Publicado: (2017)

Proteomic analysis of drug-susceptible and multidrug-resistant nonreplicating Beijing strains of Mycobacterium tuberculosis cultured in vitro
por: Saiboonjan, Bhanubong, et al.
Publicado: (2021)

A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
por: Salina, Elena G., et al.
Publicado: (2022)

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2006)

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
por: Wyatt, Linda S., et al.
Publicado: (2017)

Plasmodium berghei sporozoites in nonreplicative vacuole are eliminated by a PI3P‐mediated autophagy‐independent pathway
por: Bindschedler, Annina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2o5lsp5fgvdtdomftrlk3geaem